Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leurgans

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Neurology|February 19, 2000
Objective changes in motor function during placebo treatment in PDC G Goetz, S Leurgans, R Raman, et al.
Journal of the National Medical Association|January 19, 2002
A pilot survey of African-American physician perceptions about clinical trialsG F Lynch, P B Gorelick, R Raman, et al.
Neurology|September 20, 2000
Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patientsC G Goetz, L M Blasucci, S Leurgans, et al.
Neurology|December 30, 2004
Etanercept treatment in corticosteroid-dependent myasthenia gravisJ Rowin, M N Meriggioli, E Tüzün, et al.
Archives of Neurology|October 13, 2000
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's diseaseK Kujawa, S Leurgans, R Raman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 8, 2000
Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influencesC G Goetz, T Q Vu, P M Carvey, et al.
Neurology|January 15, 2003
Awareness, treatment, and control of vascular risk factors in African Americans with strokeS Ruland, R Raman, S Chaturvedi, et al.
Journal of Pharmaceutical Sciences|May 1, 1989
Determination of enzyme or binding constants using generalized linear models, with particular reference to Michaelis-Menten modelsG van Belle, S Leurgans, P Friel, et al.
Journal of the National Medical Association|March 27, 2003
A comparison of stroke risk factors in patients enrolled in stroke prevention trialsG F Lynch, S Leurgans, R Raman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
"On" freezing in Parkinson's disease: resistance to visual cue walking devicesK Kompoliti, C G Goetz, S Leurgans, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Neurology|February 19, 2000
Objective changes in motor function during placebo treatment in PDC G Goetz, S Leurgans, R Raman, et al.
Journal of the National Medical Association|January 19, 2002
A pilot survey of African-American physician perceptions about clinical trialsG F Lynch, P B Gorelick, R Raman, et al.
Neurology|September 20, 2000
Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patientsC G Goetz, L M Blasucci, S Leurgans, et al.
Neurology|December 30, 2004
Etanercept treatment in corticosteroid-dependent myasthenia gravisJ Rowin, M N Meriggioli, E Tüzün, et al.
Archives of Neurology|October 13, 2000
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's diseaseK Kujawa, S Leurgans, R Raman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 8, 2000
Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influencesC G Goetz, T Q Vu, P M Carvey, et al.
Neurology|January 15, 2003
Awareness, treatment, and control of vascular risk factors in African Americans with strokeS Ruland, R Raman, S Chaturvedi, et al.
Journal of Pharmaceutical Sciences|May 1, 1989
Determination of enzyme or binding constants using generalized linear models, with particular reference to Michaelis-Menten modelsG van Belle, S Leurgans, P Friel, et al.
Journal of the National Medical Association|March 27, 2003
A comparison of stroke risk factors in patients enrolled in stroke prevention trialsG F Lynch, S Leurgans, R Raman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
"On" freezing in Parkinson's disease: resistance to visual cue walking devicesK Kompoliti, C G Goetz, S Leurgans, et al.
Pageof 6